BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

Autor: Bharti, Vijaya, Watkins, Reese, Kumar, Amrendra, Shattuck-Brandt, Rebecca L., Mossing, Alexis, Mittra, Arjun, Shen, Chengli, Tsung, Allan, Davies, Alexander E., Hanel, Walter, Reneau, John C., Chung, Catherine, Sizemore, Gina M., Richmond, Ann, Weiss, Vivian L., Vilgelm, Anna E.
Zdroj: In Cell Reports 20 December 2022 41(12)
Databáze: ScienceDirect